BioLife Solutions (BLFS) Reports In-Line Q1 EPS
Tweet
Share
E-mailGet Alerts BLFS Hot Sheet
Price: $26.60 --0%
EPS Growth %: +109.1%
Financial Fact:
Product sales: 2.14M
Today's EPS Names:
JVA, ARDS, FRHC, More
EPS Growth %: +109.1%
Financial Fact:
Product sales: 2.14M
Today's EPS Names:
JVA, ARDS, FRHC, More
Join SI Premium – FREE
BioLife Solutions (NASDAQ: BLFS) reported Q1 EPS of $0.02, in-line with the analyst estimate of $0.02. Revenue for the quarter came in at $27.5 million versus the consensus estimate of $25.68 million.
GUIDANCE:
BioLife Solutions sees FY2026 revenue of $112.5-115 million, versus the consensus of $112.9 million.
For earnings history and earnings-related data on BioLife Solutions (BLFS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wolfe Research Starts SpaceX (SPCX) at Outperform
- Driven Brands (DRVN) Tops Q4 EPS by 2c, Misses on Revenue; Offers FY26 Guidance
- Morgan Stanley Upgrades Towa Pharmaceutical Co Ltd (4553:JP) to Overweight
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
